share_log

CVS Health Insiders Sell US$4.2m Of Stock, Possibly Signalling Caution

CVS Health Insiders Sell US$4.2m Of Stock, Possibly Signalling Caution

西维斯健康内部人士卖出420万美元的股票,可能表明谨慎。
Simply Wall St ·  06/30 08:13

Over the past year, many CVS Health Corporation (NYSE:CVS) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

在过去的一年里,许多西维斯健康公司(纽交所:CVS)的内部人士出售了公司的大部分股份,这可能引起了投资者的兴趣。 在评估内部交易时,知道内部人员是否在买入通常更有帮助,因为内部人员出售股票可能有各种解释。 然而,当多个内部人员在特定期间内出售股票时,股东应该注意到这可能是一个红旗。

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

虽然我们认为股东不应仅仅跟随内部人士的交易,但逻辑告诉我们,应该注意内部人士是购买还是出售股票。

The Last 12 Months Of Insider Transactions At CVS Health

CVS健康公司的过去12个月内部交易情况

Over the last year, we can see that the biggest insider sale was by the Executive VP, Prem Shah, for US$2.3m worth of shares, at about US$76.95 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (US$59.06). So it may not shed much light on insider confidence at current levels.

在过去的一年中,我们可以看到,执行副总裁Prem Shah出售了市值230万美元的股票,每股售价约76.95美元,是最大的内部人员出售。虽然我们通常不喜欢看到内部人员出售,但如果销售价格较低,则更令人担忧。有一个好消息是,这次售出发生在最新价格(59.06美元)之上。因此,这可能无法揭示内部人员对当前水平的信心。

In the last twelve months insiders purchased 12.18k shares for US$695k. But insiders sold 55.23k shares worth US$4.2m. All up, insiders sold more shares in CVS Health than they bought, over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

在过去的12个月中,内部人员购买了12.18k股,价值695k美元。但内部人员出售了总价值4.2m美元的55.23k股。总体而言,内部人员在过去一年中出售了更多CVS Health的股份。您可以在下面看到内部交易的视觉描述(由公司和个人)。通过单击下面的图表,您可以查看每笔内部交易的详细信息!

insider-trading-volume
NYSE:CVS Insider Trading Volume June 30th 2024
纽交所:CVS交易量内幕交易于2024年6月30日

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

对于那些喜欢发现潜力股票的人,可以免费查看最新内部交易股票的小盘公司名单,这可能正是您要找的机会。

Insiders At CVS Health Have Bought Stock Recently

CVS健康公司内部人员最近购买了股票

Over the last quarter, CVS Health insiders have spent a meaningful amount on shares. Not only was there no selling that we can see, but they collectively bought US$554k worth of shares. This could be interpreted as suggesting a positive outlook.

在过去的一个季度里,CVS健康公司的内部人员花费了大量资金购买股份。我们不仅没有看到任何卖出,而且他们共计购买了价值554k美元的股票。这可以被解释为对未来持续看好。

Insider Ownership

内部人员持股情况

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that CVS Health insiders own 0.1% of the company, worth about US$111m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

测试公司领导层与其他股东之间的一致性的另一种方法是查看他们拥有的股份数量。如果内部人员在公司中拥有大量股份,则这是一个好迹象。很高兴看到CVS Health的内部人员拥有公司的0.1%,价值约1.11亿美元。大多数股东都会看到这种内部持股,因为它表明管理层的激励与其他股东的激励具有很好的一致性。

What Might The Insider Transactions At CVS Health Tell Us?

CVS Health的内部交易可能告诉我们什么?

It is good to see recent purchasing. However, the longer term transactions are not so encouraging. The recent buying by some insiders , along with high insider ownership, suggest that CVS Health insiders are fairly aligned, and optimistic. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing CVS Health. For example - CVS Health has 1 warning sign we think you should be aware of.

最近的购买是好的。然而,长期的交易则不那么令人鼓舞。一些内部人员最近的购买以及高比例的内部股权表明,CVS健康公司的内部人员相当一致并且持续看好。除了了解正在进行的内部交易外,识别CVS健康公司面临的风险也是有益的。例如-CVS Health存在1个我们认为您应该了解的警告信号。

But note: CVS Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:CVS Health可能不是最好的股票买入选择。因此,查看此免费列表,其中包括ROE高且负债低的有趣公司。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发